Idera Pharmaceuticals Stock Price

-0.048 (-4.32%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Idera Pharmaceuticals Inc IDRA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.048 -4.32% 1.062 15:52:23
Open Price Low Price High Price Close Price Prev Close
1.11 1.035 1.13 1.11
Bid Price Ask Price Spread News
1.06 1.07 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,824 1,136,056 $ 1.08 $ 1,223,905 3,370,225 1.00 - 6.14
Last Trade Time Type Quantity Stock Price Currency
15:52:28 7 $ 1.0609 USD

Idera Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 53.14M 50.03M 39.41M $ - $ - -3.33 -0.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 1.70M 4.30%

more financials information »

Idera Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IDRA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.24321.261.0351.161,452,308-0.1812-14.58%
1 Month1.361.451.001.192,362,241-0.298-21.91%
3 Months5.215.831.001.943,288,286-4.15-79.62%
6 Months3.326.141.002.301,828,539-2.26-68.01%
1 Year1.846.141.002.291,031,339-0.778-42.28%
3 Years12.9617.120.8134.90656,055-11.90-91.81%
5 Years10.7226.640.81311.02920,482-9.66-90.09%

Idera Pharmaceuticals Description

Idera Pharmaceuticals Inc is a clinical-stage biopharmaceutical company involved in the discovery, development, and commercialization of innovative therapeutics for oncology and rare diseases. The company has developed two distinct proprietary drug-discovery technology platforms: Toll-like receptor and third-generation antisense technology. The Toll-like receptor technology helped the company create synthetic oligonucleotide-based drug candidates.

Your Recent History
Idera Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.